Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster

Behavioural Brain Research

Volumn 218, Issue 2, 2011, Pages 288-295

  Avolio, Ennio ^a   Alò, Raffaella ^a   Carelli, Antonio ^a   Canonaco, Marcello ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Amygdala; Anxiety; Elevated plus maze; GABA; Light dark exploration test; Orexin

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; FLUNITRAZEPAM; OREXIN; OREXIN A; OREXIN B;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; ARGYROPHILIA; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; CYTOARCHITECTURE; CYTOPLASM; GABAERGIC SYSTEM; HIBERNATION; HIPPOCAMPUS; LIGHT DARK CYCLE; MALE; MAZE TEST; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYRIAN HAMSTER;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CRICETINAE; EXPLORATORY BEHAVIOR; FLUNITRAZEPAM; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MESOCRICETUS; NEURONS; NEUROPEPTIDES; RECEPTORS, GABA-A;

EID: 79151470507     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.11.014     Document Type: Article

References (63)

1. Acuna-Goycolea C., Li Y., Van den Pol A.N. Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin/orexin neurons. J Neurosci 2004, 24. 3031-3022.
2. Adamantidis A., de Lecea L.L. The hypocretins as sensor for metabolism and arousal. J Physiol 2009, 587:33-40.
3. Berretta S. Cortico-amygdala circuits: role in the conditioned stress response. Stress 2005, 8:221-232.
4. Berridge C.W., Espana R.A. Hypocretins: waking, arousal, or action?. Neuron 2005, 46:696-698.
5. Borgland S.L., Storm E., Bonci A. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur J Neurosci 2008, 28:1545-1556.
6. Bourin M., Hascoet M. The mouse light/dark box test. Eur J Pharmacol 2003, 463:55-65.
7. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA 2005, 102:19168-19173.
8. Brundin L., Bjorkqvist M., Petersen A., Traskman-Bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol 2007, 17:573-579.
9. Bueno A., De Olmos S., Heimer L., De Olmos J. NMDA-antagonist MK-801- induced neuronal degeneration in Wistar rat brain detected by the amino-cupric-silver method. Exp Toxicol Pathol 2003, 54:319-334.
10. Canonaco M., Madeo M., Alò R., Giusi G., Granata T., Carelli A., et al. The histaminergic signaling system exerts a neuroprotective role against neurodegenerative-induced processes in the hamster. J Pharmacol Exp Ther 2005, 315:188-195.
11. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory system. Proc Natl Acad Sci USA 1999, 96:748-753.
12. de Lecea L., Jones B.E., Boutrel B., Borgland S.L., Nishino S., Bubser M., et al. Addiction and arousal: alternative roles of hypothalamic peptides. J Neurosci 2006, 26:10372-10375.
13. de Olmos J.S., Beltramino C.A., de Olmos de Lorenzo S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol Teratol 1994, 16:545-561.
14. Donatti AF, Leite-Panissi CR. GABAergic antagonist blocks the reduction of tonic immobility behavior induced by activation of 5-HT(2) receptors in the basolateral nucleus of the amygdala in guinea pigs. Brain Res Bull; 2009 [epub ahead of print].
15. Eriksson K.S., Sergeeva O., Brown R.E., Haas H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001, 21:9273-9279.
16. Facciolo R.M., Crudo M., Giusi G., Canonaco M. GABAergic influences on ORX receptor-dependent abnormal motor behaviors and neurodegenerative events in fish. Toxicol Appl Pharmacol 2010, 243:77-86.
17. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 1999, 23:743-760.
18. Gerashchenko D., Blanco-Centurion C., Greco M.A., Shiromani P.J. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience 2003, 116:223-235.
19. Giusi G., Facciolo R.M., Alò R., Carelli A., Madeo M., Brandmayr P., et al. Some environmental contaminants influence motor and feeding behaviors in the ornate wrasse (Thalassoma pavo) via distinct cerebral histamine receptor subtypes. Environ Health Perspect 2005, 113:1522-1529.
20. Giusi G., Alò R., Crudo M., Facciolo R.M., Canonaco M. Specific cerebral heat shock proteins and histamine receptor cross-talking mechanisms promote distinct lead-dependent neurotoxic responses in teleosts. Toxicol Appl Pharmacol 2008, 227:248-256.
21. He Y., Kudo M., Kudo T., Kushikata T., Li E., Hirota K. The effects of benzodiazepines on orexinergic systems in rat cerebrocortical slices. Anesth Analg 2007, 104:338-340.
22. Herwig A., Ivanova E.A., Lydon H., Barrett P., Steinlechner S., Loudon A.S. Histamine H3 receptor and orexin A expression during daily torpor in the Djungarian hamster (Phodopus sungorus). J Neuroendocrinol 2007, 12:1001-1007.
23. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S., et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 1999, 415:145-159.
24. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., Murakami N. Possible involvement of orexin in the stress reaction in rats. Bhiocem Biophys Res Commun 2000, 270:318-323.
25. Jacobson-Pick S., Elkobi A., Vander S., Rosenblum K., Richter-Levin G. Juvenile stress-induced alteration of maturation of the GABAA receptor alpha subunit in the rat. Int J Neuropsychopharmacol 2008, 11:891-903.
26. Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., et al. A key role for orexin in panic anxiety. Nat Med 2010, 16:111-115.
27. Katsuki H., Akaike A. Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation. Neuro Report 2005, 16:1157-1161.
28. Kaufmann W.A., Humpel C., Alheid G.F., Marksteiner J. Compartmentation of alpha 1 and alpha 2 GABA receptor subunits A within rat extended amygdala: implications for benzodiazepine action. Brain Res 2003, 964:91-99.
29. Krasowski M.D., Harrison N.L. General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci 1999, 55:1278-1303.
30. Kumar A., Goyal R. Possible involvement of GABAergic modulation in the protective effect of gabapentin against immobilization stress-induced behavior alterations and oxidative damage in mice. Fund Clin Pharmacol 2007, 21:575-581.
31. Làszlò K, Tòtha K, Kertesb E, Pèczelyb L, Lènàrda L. The role of neurotensin in positive reinforcement in the rat central nucleus of amygdale. Behav Brain Res; in press.
32. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
33. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005, 25:6716-6720.
34. Liu R.J., Van den Pol A.N., Aghaianian G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 2002, 22:9453-9464.
35. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001, 435:6-25.
36. Matsuki T., Nomiyama M., Takahira H., Hirashima N., Kunita S., Takahashi S., et al. Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc Natl Acad Sci USA 2009, 106:4459-4464.
37. Morin L.P., Wood R.I. A stereotaxic atlas of the golden hamster brain 2000, Academic Press.
38. Muraki Y., Yamanaka A., Tsujino N., Kilduff T.S., Goto K., Sakurai T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 2004, 24:7159-7166.
39. Muroya S., Funahashi H., Yamanaka A., Kohno D., Uramura K., Nambu T., et al. Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur J Neurosci 2004, 19:1524-1534.
40. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999, 827:243-260.
41. Passerin A.M., Cano G., Rabin S., Delano B.A., Napier J.L., Sved A.F. Role of locus coeruleus in foot shock-evoked Fos expression in rat brain. Neuroscience 2000, 101:1071-1082.
42. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 1986, 24:525-529.
43. Petersen A., Gil J., Maat-Schieman M.L., Bjorkqvist M., Tanila H., Araujo I.M., et al. Orexin loss in Huntington's disease. Hum Mol Genet 2005, 14:39-47.
44. Petrovich G.D., Canteras N.S., Swanson L.W. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res Rev 2001, 38:247-289.
45. Pyner S. Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation. J Chem Neuroanat 2009, 38:197-208.
46. Reynolds D.S., Ferris P., Lincoln R.J., Stanley J.L., cook S.M., Alder L., et al. Which GABAA receptor subtype mediates the anxiolytic effects of benzodiazepines: is it alpha2 or alpha3?. FENS Forum Abstr 2002, 1:154-213.
47. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., et al. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology 2008, 199:109-117.
48. Rodgers R.J., Ishii Y., Halford J.C.G., Blundell J.E. Orexins and appetite regulation. Neuropeptides 2002, 36:303-325.
49. Rosenkranz J.A., Buffalari D.M., Grace A.A. Opposing influence of basolateral amygdala and footshock stimulation on neurons of the central amygdala. Biol Psychiatry 2006, 59:801-811.
50. Sah P., Faber E.S., Lopez D.A., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 2003, 83:803-834.
51. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and Orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
52. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007, 8:171-181.
53. Saldivar-Gonzales J.A., Posadas-Andrews A., Rodriguez R., Gomez C., Hernandez-Manjarrez M.E., Ortiz-Leon S., et al. Effect of electrical stimulation of the basolateral amygdala nucleus on defensive burying shock-rove test and elevated plus maze in rats. Life Sci 2003, 72:819-829.
54. Samir H.D., Roh-Yu S. The wake-promoting peptide Orexin-B Inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J Neurosci 2005, 25:896-905.
55. Santhakumar V., Jones R.T., Mody I. Developmental regulation and neuroprotective effects of striatal tonic GABAA currents. Neurosci 2010, 167:644-655.
56. Singewald N., Salchner P., Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 2003, 15:275-283.
57. Teske J.A., Billington C.J., Kotz C.M. Hypocretin/orexin and energy expenditure. Acta Physiol 2010, 3:303-312.
58. Thannickal T.C., Lai Y.Y., Siegel J.M. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007, 130:1586-1595.
59. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 2004, 24:11439-11448.
60. Yoshida K., McCormack S., Espana R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. J Comp Neurol 2006, 494:845-861.
61. Zhang F., Li C., Wang R., Han D., Zhang Q.G., Zhou C., et al. Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. Neuroscience 2007, 150:938-949.
62. Zhou C., Li C., Yu H.M., Zhang F., Han D., Zhang G.Y. Neuroprotection of caminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia. J Neurosci Res 2008, 86:2973-2983.
63. Zhu X., Smith M.A., Perry G., Wang Y., Ross A.P., Zhao H.W., et al. MAPKs are differentially modulated in arctic round squirrels during hibernation. J Neurosci Res 2005, 80:862-868.